$0.6354
-0.0479-7.01%
Last update: Nov 6, 7:04 AM
Cognition Therapeutics Inc
CGTXNASDAQ
Cognition Therapeutics (CGTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.06 | $-0.07 | $-0.07 |
| Actual | $-0.04 | $-0.04 | $-0.05 | $-0.01 |
| Surprise | +42.9% | +33.3% | +28.6% | +85.7% |
| Revenue | ||||
| Estimate | $1.1M | $1.0M | $880000 | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | -100.0% | -100.0% | -100.0% | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.14 | $-0.05 | $-0.05 | $-0.05 |
| Revenue | ||||
| Consensus | $800000 | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.04 | $-0.07 | 42.9 % |
| Q2 | Aug 6, 2026 | $-0.04 | $-0.06 | 33.3 % |
| Q1 | May 7, 2026 | $-0.05 | $-0.07 | 28.6 % |
| Q4 | Mar 26, 2026 | $-0.01 | $-0.07 | 85.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0 | $1.06M | -100.0 % |
| Q2 | Aug 6, 2026 | $0 | $1.00M | -100.0 % |
| Q1 | May 7, 2026 | $0 | $880.00K | -100.0 % |
